MRI in Staging Ovarian Cancer Using MRI Contrast Agent

Værdien af MRI Til Staging af c.Ovarii-et Prospektivt Studie

Status

UNKNOWN

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT00463996

Enrollment

Registered

2007-04-20

Start date

2007-04-30

Completion date

2008-04-30

Last updated

2007-04-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ovarian Cancer

Keywords

Ovarian cancer, MRI, Contrast agent

Brief summary

Can MRI be used to stage ovarian cancer?

Detailed description

Staging of ovarian cancer can best be performed with CT or MRI compared to ultrasound. Studies have shown an increase in pos. predictive value by adding contrast i.v. to the MR-examination protocol. We compare staging of ovarian cancer by 1.MRI without contrast (standard method) to 2.MRI with contrast agent i.v. (new method)in the same patient. Golden standard are findings at operation.

Interventions

None listed

Study design

Observational model

CASE_CONTROL

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

FEMALE

Healthy volunteers

Inclusion criteria

* suspicion of ovarian cancer

Exclusion criteria

* recurrence of disease * contraindication to MRI, contrast agent * inoperable patients for other reasons

Contacts

Primary ContactLiselotte Ibsen, doc

+4589495201

Backup ContactErik Lundorf, consultant

elu@sks.aaa.dk+4589495251

Outcome results